2020
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
Campbell KH, Tornatore JM, Lawrence KE, Illuzzi JL, Sussman LS, Lipkind HS, Pettker CM. Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut. JAMA 2020, 323: 2520-2522. PMID: 32453390, PMCID: PMC7251498, DOI: 10.1001/jama.2020.8904.Peer-Reviewed Original ResearchMeSH KeywordsAdultAsymptomatic DiseasesBetacoronavirusClinical Laboratory TechniquesConnecticutCoronavirus InfectionsCOVID-19COVID-19 TestingDelivery, ObstetricFemaleHumansInfectious Disease Transmission, Patient-to-ProfessionalPandemicsParturitionPersonal Protective EquipmentPneumonia, ViralPregnancyPregnancy Complications, InfectiousPrevalenceSARS-CoV-2
2014
Patient and provider perspectives on Bedsider.org, an online contraceptive information tool, in a low income, racially diverse clinic population
Gressel GM, Lundsberg LS, Illuzzi JL, Danton CM, Sheth SS, Xu X, Gariepy A. Patient and provider perspectives on Bedsider.org, an online contraceptive information tool, in a low income, racially diverse clinic population. Contraception 2014, 90: 588-593. PMID: 25139723, DOI: 10.1016/j.contraception.2014.07.010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultContraceptionContraception BehaviorCounselingFamily Planning ServicesFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHealth PersonnelHumansInformation Seeking BehaviorInternetPatient Education as TopicPerceptionPovertyPregnancyUnited StatesWomen's HealthYoung AdultConceptsClinic providersPatient participantsDiverse clinic populationProvider perspectivesHealth careUrban clinic settingWomen ages 18Women's health careProviders/staffNew contraceptive methodsStructured interview guideUrban MedicaidUrban clinicClinic populationActive womenClinic settingUnplanned pregnancyContraceptive methodsPatientsProviders' understandingContraceptive educationAge 18Contraceptive toolAmerican CongressClinic
2011
A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study
El-Sahwi KS, Illuzzi J, Varughese J, Carusillo N, Ratner ES, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD. A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study. Gynecologic Oncology 2011, 124: 471-473. PMID: 22014628, DOI: 10.1016/j.ygyno.2011.09.029.Peer-Reviewed Original ResearchConceptsWithdrawal of carePercent of respondentsGynecologic oncologistsLife discussionsAdvanced-stage cancerProgression of diseaseYears of ageFirst recurrenceMajor surgeryPatient ageHalf of respondentsStage cancerMedical statusResponse rateTumor sitePatientsOncologistsPilot studyPilot surveyHealth insuranceInitial responseSurvey MonkeyAgeSocial supportCare
2008
Effect of 2 stitches vs 1 stitch on the prevention of preterm birth in women with singleton pregnancies who undergo cervical cerclage
Woensdregt K, Norwitz ER, Cackovic M, Paidas MJ, Illuzzi JL. Effect of 2 stitches vs 1 stitch on the prevention of preterm birth in women with singleton pregnancies who undergo cervical cerclage. American Journal Of Obstetrics And Gynecology 2008, 198: 396.e1-396.e7. PMID: 18177834, PMCID: PMC2757008, DOI: 10.1016/j.ajog.2007.10.782.Peer-Reviewed Original ResearchConceptsCervical cerclageSingleton pregnanciesPreterm birthGestational ageRetrospective cohort studyWeeks of gestationCerclage groupClinical characteristicsCohort studyAge cutBaseline differencesLarge cohortCerclagePregnancyFurther studiesSignificant differencesPatientsBirthPreventionStitchesAgeMeasurable benefitsDeliveryGestationGroupCarcinosarcoma of the ovary
Silasi D, Illuzzi J, Kelly M, Rutherford T, Mor G, Azodi M, Schwartz P. Carcinosarcoma of the ovary. International Journal Of Gynecological Cancer 2008, 18: 22. DOI: 10.1136/ijgc-00009577-200801000-00004.Peer-Reviewed Original ResearchProgression-free intervalMedian progression-free intervalAdvanced stage diseaseMedian survivalOptimal cytoreductionOvarian carcinosarcomaStage diseaseTaxol groupEffective cytotoxic regimenFirst-line cisplatinFirst-line chemotherapyCombination of carboplatinEpithelial ovarian cancerCytotoxic regimenIfosfamide groupAdjuvant cisplatinEntire cohortMedical recordsOvarian cancerCytoreductionPatientsSurvival rateCarcinosarcomaCarboplatinCisplatin
2007
Carcinosarcoma of the ovary
SILASI D, ILLUZZI JL, KELLY MG, RUTHERFORD TJ, MOR G, AZODI M, SCHWARTZ PE. Carcinosarcoma of the ovary. International Journal Of Gynecological Cancer 2007, 18: 22-29. PMID: 17451459, DOI: 10.1111/j.1525-1438.2007.00948.x.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCarboplatinCarcinosarcomaChemotherapy, AdjuvantCisplatinCombined Modality TherapyDisease-Free SurvivalFemaleHumansIfosfamideMiddle AgedOvarian NeoplasmsPaclitaxelRegistriesRetrospective StudiesSurvival RateTreatment OutcomeConceptsProgression-free intervalMedian progression-free intervalAdvanced stage diseaseMedian survivalOptimal cytoreductionOvarian carcinosarcomaStage diseaseTaxol groupEffective cytotoxic regimenFirst-line cisplatinFirst-line chemotherapyCombination of carboplatinEpithelial ovarian cancerCytotoxic regimenIfosfamide groupAdjuvant cisplatinEntire cohortMedical recordsOvarian cancerCytoreductionPatientsSurvival rateCarcinosarcomaCarboplatinCisplatin